Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6552045B2 · kind B2 · utility
12Cited by
38References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2002 |
| Grant date | Apr 22, 2003 |
| Priority date | — |
| Expiry date | Jan 10, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods and compositions for the prevention, treatment, or management of gastrointestinal disorders or symptoms thereof, employing two or more agents or compounds to provide a triple site action on 5-HT3 receptors, 5-HT4 receptors, and at least one of H2 receptors and proton pumps.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.